Newpath Partners GP IV, L.P.

About Newpath Partners GP IV, L.P.

Newpath Partners GP IV, L.P. is the general partner entity for Newpath Partners IV, the second fund raised by Newpath Partners, a Boston-based venture capital firm founded in 2018 by physician-scientist Thomas Cahill to build biotechnology companies from the ground up. The firm’s investment thesis is stage-agnostic but centers exclusively on life sciences and biotechnology, partnering with leading academic scientists to translate groundbreaking discoveries into therapies, with primary focus on regenerative medicine, genomics, and oncology. Newpath typically leads Series A rounds with check sizes of $50M–$200M+ and also invests $10M–$50M in seed-stage company formations, acting as a lead investor rather than a follower. Notable portfolio companies include Prime Medicine, Chroma Medicine, Autobahn Therapeutics, and Metsera, all built through its company-formation model. A distinctive point of view is that venture capital should create companies rather than merely fund them, combining capital with operational expertise, board experience, and deep scientific credibility. This approach has yielded a portfolio of 13+ companies across breakthrough biolo

Newpath Partners GP IV, L.P. at a glance

Also known as

Newpath Partners IV

Location

Boston, MA, USA

Investor type

Venture Capital

Frequently asked about Newpath Partners GP IV, L.P.

What does Newpath Partners GP IV, L.P. invest in?

We have not verified a stated sector or stage focus for Newpath Partners GP IV, L.P. at Newpath Partners IV (Boston, MA, USA). The profile lists the organization, location and investors we track alongside them.

How do I contact Newpath Partners GP IV, L.P.?

Newpath Partners GP IV, L.P.'s published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.

Where is Newpath Partners GP IV, L.P. headquartered?

Newpath Partners GP IV, L.P. is based in Boston, MA, USA.

StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Boston.

Investors similar to Newpath Partners GP IV, L.P. (20)

• Vikram Deswal
• John Kelly
• Stoddard M. Wilson
• Tom Rutledge
• Joichi Ito
• Joi Ito
• Wellington Management Company LLP
• Jason Morris
• Margaret Hall
• Bob Davoli
• Will Herman
• Summit Partners Public Asset Management, LLC
• Point Judith Capital (PJC)
• Gregory Avis
• Udi Mokady
• Dewey J. Awad
• Peter Y. Chung
• Bonbillo LLC
• Edward B. Roberts
• Paul Sagan

Browse related investor lists (2)

• Investors in Boston, MA, USA
• Venture Capital investors

Compare Newpath Partners GP IV, L.P. (8)

• Newpath Partners GP IV, L.P. vs Vikram Deswal
• Newpath Partners GP IV, L.P. vs John Kelly
• Newpath Partners GP IV, L.P. vs Stoddard M. Wilson
• Newpath Partners GP IV, L.P. vs Tom Rutledge
• Newpath Partners GP IV, L.P. vs Joichi Ito
• Newpath Partners GP IV, L.P. vs Joi Ito
• Newpath Partners GP IV, L.P. vs Wellington Management Company LLP
• Newpath Partners GP IV, L.P. vs Jason Morris

Investors like Newpath Partners GP IV, L.P. · Full investor directory · Investor access · Company funding database